Lg Chem Drug Patent Portfolio
Lg Chem owns 1 orange book drug protected by 9 US patents Given below is the list of Lg Chem's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6262071 | Methods of use of antimicrobial compounds against pathogenic amycoplasma bacteria | 21 Sep, 2019 | Expired |
| US6331550 | Methods of use of quinolone compounds against anaerobic pathogenic bacteria | 21 Sep, 2019 | Expired |
| US6455540 | Methods of use of quinolone compounds against anaerobic pathogenic bacteria | 21 Sep, 2019 | Expired |
| US6803376 | Method of use of quinolone compounds against pneumococcal and haemophilus bacteria | 21 Sep, 2019 | Expired |
| US6340689 | Methods of use of quinolone compounds against atypical upper respiratory pathogenic bacteria | 14 Sep, 2019 | Expired |
| US6723734 | Salt of naphthyridine carboxylic acid derivative | 20 Mar, 2018 | Expired |
| US5776944 | 7-(4-aminomethyl-3-methyloxyiminopyrroplidin-1-yl)-1-cyclopropyl-6-flu oro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid and the process for the preparation thereof | 04 Apr, 2017 | Expired |
| US5633262 | Quinoline carboxylic acid derivatives having 7-(4-amino-methyl-3-oxime) pyrrolidine substituent and processes for preparing thereof | 15 Jun, 2015 | Expired |
| US5962468 | 7-(4-aminomethyl-3-methyloxyiminopyrrolidin-1-yl)-1- cyclopropyl-6-fluoro-4-oxo-1, 4-dihydro-1, 8-naphthyridine-3-carboxylic acid and the process for the preparation thereof | 15 Jun, 2015 | Expired |
Latest Legal Activities on Lg Chem's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Lg Chem.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
|
Recordation of Patent Grant Mailed
Critical
| 20 Apr, 2004 | US6723734 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 20 Apr, 2004 | US6723734 |
|
Issue Notification Mailed
Critical
| 01 Apr, 2004 | US6723734 |
| Receipt into Pubs | 22 Mar, 2004 | US6723734 |
|
Application Is Considered Ready for Issue
Critical
| 18 Mar, 2004 | US6723734 |
| Receipt into Pubs | 16 Mar, 2004 | US6723734 |
|
Response to Amendment under Rule 312
Critical
| 12 Mar, 2004 | US6723734 |
|
Mail Response to 312 Amendment (PTO-271)
Critical
| 12 Mar, 2004 | US6723734 |
|
Issue Fee Payment Received
Critical
| 16 Jan, 2004 | US6723734 |
|
Issue Fee Payment Verified
Critical
| 16 Jan, 2004 | US6723734 |
| Receipt into Pubs | 17 Dec, 2003 | US6723734 |
|
Amendment after Notice of Allowance (Rule 312)
Critical
| 05 Nov, 2003 | US6723734 |
| Receipt into Pubs | 04 Nov, 2003 | US6723734 |
| Workflow - File Sent to Contractor | 04 Nov, 2003 | US6723734 |
| Dispatch to Publications | 31 Oct, 2003 | US6723734 |
Lg Chem's Family Patents
Lg Chem Drug List
Given below is the complete list of Lg Chem's drugs and the patents protecting them.
1. Factive
Factive is protected by 9 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6262071 | Methods of use of antimicrobial compounds against pathogenic amycoplasma bacteria |
21 Sep, 2019
(6 years ago)
| Expired |
| US6331550 | Methods of use of quinolone compounds against anaerobic pathogenic bacteria |
21 Sep, 2019
(6 years ago)
| Expired |
| US6455540 | Methods of use of quinolone compounds against anaerobic pathogenic bacteria |
21 Sep, 2019
(6 years ago)
| Expired |
| US6803376 | Method of use of quinolone compounds against pneumococcal and haemophilus bacteria |
21 Sep, 2019
(6 years ago)
| Expired |
| US6340689 | Methods of use of quinolone compounds against atypical upper respiratory pathogenic bacteria |
14 Sep, 2019
(6 years ago)
| Expired |
| US6723734 | Salt of naphthyridine carboxylic acid derivative |
20 Mar, 2018
(7 years ago)
| Expired |
| US5776944 | 7-(4-aminomethyl-3-methyloxyiminopyrroplidin-1-yl)-1-cyclopropyl-6-flu oro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid and the process for the preparation thereof |
04 Apr, 2017
(8 years ago)
| Expired |
| US5633262 | Quinoline carboxylic acid derivatives having 7-(4-amino-methyl-3-oxime) pyrrolidine substituent and processes for preparing thereof |
15 Jun, 2015
(10 years ago)
| Expired |
| US5962468 | 7-(4-aminomethyl-3-methyloxyiminopyrrolidin-1-yl)-1- cyclopropyl-6-fluoro-4-oxo-1, 4-dihydro-1, 8-naphthyridine-3-carboxylic acid and the process for the preparation thereof |
15 Jun, 2015
(10 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Factive's drug page
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List